2016 Annual Resu sults ts Midatech Pharma plc April 2017 - PowerPoint PPT Presentation

Mar 30, 2024 •460 likes •752 views

2016 Annual Resu sults ts Midatech Pharma plc April 2017 Disclaimer THIS PRESENTATION MAY NOT BE COPIED OR REPRODUCED IN ANY FORM, FURTHER DISTRIBUTED OR PASSED ON, DIRECTLY OR INDIRECTLY, TO ANY OTHER PERSON, OR PUBLISHED, IN WHOLE OR IN

2016 Annual Resu sults ts Midatech Pharma plc April 2017

Download Presentation

Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend

Ah Ahol old D d Del elha haize e Q2 2 2 201 019 re resu sults ts August 7, 2019 Hi

Ah Ahol old D d Del elha haize e Q2 2 2 201 019 re resu sults ts August 7, 2019 Hi High ghli ligh ghts ts Frans Muller President & CEO 2 Second d qu quar arter ter resu sults lts impa pacte cted d by by Stop p

333 views • 16 slides

2016 16 Hal alf-ye year ar resu sults lts presen sentat tation ion 19 May 2016 Andrew

2016 16 Hal alf-ye year ar resu sults lts presen sentat tation ion 19 May 2016 Andrew Rashbass, CEO Cont ntext xt Weak first half the run- off of operational deficit last year and first quarter of this combined with

761 views • 47 slides

2016 I 6 Interim R Resu sults P s Prese sentation Scott M McGr Greg egor, C Chi hief E

2016 I 6 Interim R Resu sults P s Prese sentation Scott M McGr Greg egor, C Chi hief E Exec ecutive e Officer er Scott L Lair ird, Fin inance D Dir irector 28 th September 2016 28 2016 H1 2016 Highlights Market seeding

445 views • 21 slides

Sec econ ond d Qua uarter er 20 2017 Re 7 Resu sults August 9, 2017 Q2 Q2 Hi High ghli

1 Sec econ ond d Qua uarter er 20 2017 Re 7 Resu sults August 9, 2017 Q2 Q2 Hi High ghli ligh ghts ts Dick Boer President and CEO 3 Second Quarte rter r 2017 7 Results sults Highlights second quarter 2017 Improved pro

295 views • 29 slides

RESU SULTS TS PRESE SENT NTATION ION WARSAW , 17 TH MAY 2018 Disclaimer This is pr

1Q18 1Q18 FINA FINANC NCIA IAL RESU SULTS TS PRESE SENT NTATION ION WARSAW , 17 TH MAY 2018 Disclaimer This is pr presentati tation (th (the Presentation) was pr prepar ared by by LPP SA SA (th (the Company) with ith

667 views • 49 slides

Nexan Ne xans 20 2019 19 Fu Full ll Ye Year ar Re Resu sults lts th Februa Paris, s,

Nexan Ne xans 20 2019 19 Fu Full ll Ye Year ar Re Resu sults lts th Februa Paris, s, 20 th ruary ry 2020 Safe Harbor This presentation contains forward-looking statements which are subject to various expected or unexpected risks and

611 views • 39 slides

Thi hird d Qua uarter er 20 2018 Re 8 Resu sults November 7, 2018 Q3 Q3 Hi High ghli

Thi hird d Qua uarter er 20 2018 Re 8 Resu sults November 7, 2018 Q3 Q3 Hi High ghli ligh ghts ts Frans Muller President and CEO Highli hlights hts Third ird qu quar arter ter 2018 Strong sales and earnings growth,

395 views • 18 slides

Thi hird d Qua uarter er 20 2017 Re 7 Resu sults November 8, 2017 Q3 Q3 Hi High ghli

Thi hird d Qua uarter er 20 2017 Re 7 Resu sults November 8, 2017 Q3 Q3 Hi High ghli ligh ghts ts Dick Boer President and CEO 3 Third ird Quarte rter r 2017 7 Resul ults ts Highlights third quarter 2017 Pro forma net

402 views • 22 slides

FULL FULL YEAR R RE RESU SULTS S 2019 2019 Joa Joachim im Dr rr (CE (CEO) Chr

J O S T W E R K E A G M A R C H 2 5 , 2 0 2 0 FULL FULL YEAR R RE RESU SULTS S 2019 2019 Joa Joachim im Dr rr (CE (CEO) Chr Chris istia ian Ter erli linde (CF (CFO) Disclaimer THIS PRESENTATION IS CONFIDENTIAL AND

586 views • 22 slides

FY FY19 R Resu sults P s Prese sentation Fo For the year ended 31 March 2019 an and Ou

FY FY19 R Resu sults P s Prese sentation Fo For the year ended 31 March 2019 an and Ou Outlo look for FY20 20 29 May 2019 PACIFIC EDGE IS IN A UNIQUE GLOBAL POSITION (PEB.NZX) First to market for 17 years: Four proprietary,

384 views • 26 slides

INTER INT ERIM IM RE RESU SULTS INVESTOR IN OR PR PRESEN ENTATION TION Paul Swinney CEO

plc lc 31 DE 1 DECEMB MBER 20 2017 INTER INT ERIM IM RE RESU SULTS INVESTOR IN OR PR PRESEN ENTATION TION Paul Swinney CEO Liz Dixon FD FI FINANCIAL ANCIAL HI HIGHL HLIGHT IGHTS UP 10% UP 18% PRE-TAX PROFIT* REVENUE TO

429 views • 20 slides

WATKIN JONE N JONES PL PLC HALF Y HA YEAR RE R RESU SULTS To 31 1 Ma March 20 2018 8 22

Mar ark W Wat atkin Jon ones es CEO Philip ilip B Byrom CFO FO WATKIN JONE N JONES PL PLC HALF Y HA YEAR RE R RESU SULTS To 31 1 Ma March 20 2018 8 22 nd May 2018 FINANCIAL IAL H HIGHLIG IGHTS Bagot ot S Street

876 views • 31 slides

APB M Methods a and Prelimi minary Rese search R Resu sults ts Mark Newton Lowry David

APB M Methods a and Prelimi minary Rese search R Resu sults ts Mark Newton Lowry David Hovde Zack Legge Pacific Economics Group Research, LLC Ontario Energy Board 29 October 2018 Toronto, ON 2 Overview ew Benchmarking Basics

757 views • 60 slides

Fixed Income Investor Presentation H1 H1 2018 R 2018 Resu sults 3r 3rd A d August 2018

Fixed Income Investor Presentation H1 H1 2018 R 2018 Resu sults 3r 3rd A d August 2018 2018 Katie Murray Deputy CFO 2 Summary financials vs. H1 2017 6.7 .7bn Inc ncome (3.1%) 6,919 89 (109) 99 6,702 (296) Inco come (

339 views • 22 slides

Up Update date on 20 n 2018 18 Asses As sessm smen ent t Re Resu sults lts STATE

Up Update date on 20 n 2018 18 Asses As sessm smen ent t Re Resu sults lts STATE BOARD OF EDUCATION November 7, 2018 Michaela W. Miller, Ed.D., NBCT Deputy Superintendent Deb Came, Ph.D. Assistant Superintendent, Assessment and

590 views • 21 slides

INTE TERIM R RESU SULTS TS For the the S Six M Mont nths e end nded 30 30 September

INTE TERIM R RESU SULTS TS For the the S Six M Mont nths e end nded 30 30 September 2019 2019 Highlights FY2019 H1 FY2020 H1 Change FY2020 H1 excl. IFRS reported reported 16 impact Net sales (million ) 595.4 727.2 +22.1%

416 views • 23 slides

InnoCare Pharma 2019 Annual Report Presentation April 2020 Disclaimer These materials are for

InnoCare Pharma 2019 Annual Report Presentation April 2020 Disclaimer These materials are for information purposes only and do not constitute or form part of an offer or invitation to sell or issue or the solicitation of an offer or invitation to

724 views • 37 slides

COVID-19 and Celiac Disease Dr Donald Duerksen Chair Professional Advisory Committee Canadian

COVID-19 and Celiac Disease Dr Donald Duerksen Chair Professional Advisory Committee Canadian Celiac Association COVID-19 Canada April 27, 2020 COVID-19 Information Overload! COVID-19 is found in the stool There are ACE receptors

382 views • 15 slides

Ecology, Epidemiology, and Prevention of Lyme Disease in the United States Paul Mead, MD, MPH

Ecology, Epidemiology, and Prevention of Lyme Disease in the United States Paul Mead, MD, MPH Chief, Epidemiology and Surveillance Activity Division of Vector-Borne Diseases National Center for Emerging and Zoonotic Infectious Diseases Centers

770 views • 73 slides

XTL BIOPHARMACEUTICALS TO PRESENT AT BIOTECH SHOWCASE RAANANA, ISRAEL - (December 19, 2016) XTL

XTL BIOPHARMACEUTICALS TO PRESENT AT BIOTECH SHOWCASE RAANANA, ISRAEL - (December 19, 2016) XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTLB.TA) ( XTL or the Company ), a clinical-stage biopharmaceutical company developing

295 views • 3 slides

Where we learn. There is no mold, -ACPS facilities Mold Inspection Network Lab Rating Scale

Where we learn. There is no mold, -ACPS facilities Mold Inspection Network Lab Rating Scale (Concentration of Spores) 0 1 2 3 4 5 No Species Found Scattered Very Low Low Medium High Nearly 60% of 7th grade classroom tested

325 views • 14 slides

Presentation of Diarrhoea Differential diagnosis of diarrhoea Infectious: o Viral

Presentation of Diarrhoea Differential diagnosis of diarrhoea Infectious: o Viral Norovirus; Rotavirus o Bacterial E.coli; Salmonella; Shigella; Campylobacter Vibrio cholerae C. difficile o Protozoal/parasites Giardia

455 views • 3 slides

NCI Experience Using Yeast brachyury Vaccine (GI 6301) in Patients with Advanced Chordoma

NCI Experience Using Yeast brachyury Vaccine (GI 6301) in Patients with Advanced Chordoma Christopher R. Heery, M.D. Laboratory of Tumor Immunology and Biology and Medical Oncology Branch National Cancer Institute, CCR, NCI, NIH

276 views • 25 slides

New Paradig Paradigms for Adv s for Advancing ncing Perso Personalized alized Medicine

1 2 New Paradig Paradigms for Adv s for Advancing ncing Perso Personalized alized Medicine Medicine 1 Pane Panelists lists Moderated by: Antoinette Konski Antoinette Konski, Partner, Foley & Lardner LLP Speakers: Anita Chawla,

351 views • 11 slides